Board of Directors

Tomas Babak, PhD
Founder and CEO

Over the past two decades, contributing to the development of new drugs in biopharma, Tomas grew increasingly frustrated with the lack of accurate models and tools for predicting how a drug will fare when it is finally tested in the clinic. Tomas ultimately founded Leapfrog Bio to tackle this challenge head on. Past experience includes leading computational and methods development groups at Merck, Celgene, and BMS to help bridge the gap between genomics and drug development, as well as leading an academic group as an Assistant Professor focusing on mapping noncoding driver genes.
Past experience includes leading computational and methods development groups at Merck, Celgene, and BMS to help bridge the gap between genomics and drug development, as well as leading an academic group as an Assistant Professor focusing on mapping noncoding driver genes.

Read More

Mike Goguen, MSEE
Founder and Managing Partner at Two Bear Capital

A veteran of Sequoia Capital, Mike sponsored 54 investments over 20 years that yielded a combined market value of over $64B. As the Founder and Managing Partner at Two Bear Capital, Mike continues to lead investments in biotech, health care IT, and information security.